These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24389217)

  • 1. Endothelial dysfunction in the pathogenesis of pre-eclampsia.
    Szpera-Gozdziewicz A; Breborowicz GH
    Front Biosci (Landmark Ed); 2014 Jan; 19(5):734-46. PubMed ID: 24389217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
    Govender N; Naicker T; Rajakumar A; Moodley J
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis.
    Kleinrouweler CE; Wiegerinck MM; Ris-Stalpers C; Bossuyt PM; van der Post JA; von Dadelszen P; Mol BW; Pajkrt E;
    BJOG; 2012 Jun; 119(7):778-87. PubMed ID: 22433027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.
    Maynard SE; Min JY; Merchan J; Lim KH; Li J; Mondal S; Libermann TA; Morgan JP; Sellke FW; Stillman IE; Epstein FH; Sukhatme VP; Karumanchi SA
    J Clin Invest; 2003 Mar; 111(5):649-58. PubMed ID: 12618519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble fms-like tyrosine kinase 1 and soluble endoglin are elevated circulating anti-angiogenic factors in pre-eclampsia.
    Liu Z; Afink GB; Dijke PT
    Pregnancy Hypertens; 2012 Oct; 2(4):358-67. PubMed ID: 26105603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro.
    Xu B; Thornton C; Tooher J; Ogle R; Lim S; Makris A; Hennessy A
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):839-42. PubMed ID: 19215236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion.
    Soto E; Romero R; Kusanovic JP; Ogge G; Hussein Y; Yeo L; Hassan SS; Kim CJ; Chaiworapongsa T
    J Matern Fetal Neonatal Med; 2012 May; 25(5):498-507. PubMed ID: 21867402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
    Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
    J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction in pre-eclampsia.
    Poston L
    Pharmacol Rep; 2006; 58 Suppl():69-74. PubMed ID: 17332674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia.
    Wang K; Ahmad S; Cai M; Rennie J; Fujisawa T; Crispi F; Baily J; Miller MR; Cudmore M; Hadoke PW; Wang R; Gratacós E; Buhimschi IA; Buhimschi CS; Ahmed A
    Circulation; 2013 Jun; 127(25):2514-22. PubMed ID: 23704251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation by an angiogenic imbalance leads to systemic vascular endothelial dysfunction: A new proposal for the pathophysiology of preeclampsia.
    Matsuyama T; Tomimatsu T; Mimura K; Yagi K; Kawanishi Y; Kakigano A; Nakamura H; Endo M; Kimura T
    J Reprod Immunol; 2021 Jun; 145():103322. PubMed ID: 33887508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of angiogenic factors in the pathogenesis and management of pre-eclampsia.
    Ngene NC; Moodley J
    Int J Gynaecol Obstet; 2018 Apr; 141(1):5-13. PubMed ID: 29222938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New insights in the pathophysiology of preeclampsia and potential therapeutic implications].
    Boulanger H; Flamant M
    Nephrol Ther; 2007 Dec; 3(7):437-48. PubMed ID: 18047998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.
    Cheng M; He P; Fu J
    J Hum Hypertens; 2016 Dec; 30(12):788-793. PubMed ID: 27169826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New insights into the pathogenesis of pre-eclampsia: the role of angiogenesis-inhibiting factors].
    Verdonk K; Visser W; Steegers EA; Kappers M; Danser AH; van den Meiracker AH
    Ned Tijdschr Geneeskd; 2011; 155():A2946. PubMed ID: 21486506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
    Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE
    Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoadiponectinemia and circulating angiogenic factors in overweight patients complicated with pre-eclampsia.
    Suwaki N; Masuyama H; Nakatsukasa H; Masumoto A; Sumida Y; Takamoto N; Hiramatrsu Y
    Am J Obstet Gynecol; 2006 Dec; 195(6):1687-92. PubMed ID: 16769024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of preeclampsia.
    Mutter WP; Karumanchi SA
    Microvasc Res; 2008 Jan; 75(1):1-8. PubMed ID: 17553534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia.
    Cim N; Kurdoglu M; Ege S; Yoruk I; Yaman G; Yildizhan R
    J Matern Fetal Neonatal Med; 2017 Jul; 30(13):1602-1607. PubMed ID: 27658884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.